Genomic alterations in oral squamous cell carcinoma cell lines detected by two-dimensional gel analysis

Oral Oncology

Volumn 34, Issue 6, 1998, Pages 508-512

  Yamamoto, K ^a   Konishi, N ^a   Inui, T ^a   Kitahori, Y ^a   Hiasa, Y ^a   Kirita, T ^a   Sugimura, M ^a  

^a NARA MEDICAL UNIVERSITY   (Japan)

Author keywords

Cell line; Genome; Oral squamous cell carcinoma; RLGS

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CANCER GENETICS; DNA DETERMINATION; GENE AMPLIFICATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; MOUTH CARCINOMA; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

CARCINOMA, SQUAMOUS CELL; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HUMANS; MOUTH NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0031761962     PISSN: 13688375     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1368-8375(98)00030-X     Document Type: Article

References (22)

1. Stell P. M. Survival time in endo-stage head and neck cancer. European Journal of Oncology. 15:1989;407-410.
2. Ankita M. P., Leonard S. I., Gary L. S., William J. W., Kenneth D. S. Amplification and expression of EMS-1 (cortactin) in head and neck squamous cell carcinoma cell lines. Oncogene. 12:1996;31-35.
3. Califano J., Van Riet P., Westra W., et al. Genetic progression model for head and neck cancer: implications for field cancerization. Cancer Research. 56:1996;2488-2492.
4. Bockmühl U., Schwendel A., Dietel M., Petersen I. Distinct patterns of chromosomal alterations in high- and low-grade head and neck squamous cell carcinomas. Cancer Research. 56:1996;5325-5329.
5. Komiyama T., Matsumura K., Tsuchida M. Comparison of DNA copy numbers in original oral squamous cell carcinomas and corresponding cell lines by comparative genomic hybridization. Japanese Journal of Cancer Research. 88:1997;476-483.
6. Matsumura K. Detection of DNA amplifications and deletions in oral squamous cell carcinoma cell lines by comparative genomic hybridization (CGH). Journal of Stomatology Society Japan. 62:1995;513-531.
7. Presti J. C. Jr, Moch H., Reuter V. E., Cordon-Cardo C., Waldman F. M. Renal cell carcinoma genetic analysis by comparative genomic hybridization and restriction fragment length polymorphism analysis. Journal of Urology. 156:1996;281-285.
8. Hirotsune S., Hatada I., Komatubara H., et al. New approach for detection of amplification in cancer DNA using restriction landmark genomic scanning method. Cancer Research. 52:1992;3642-3647.
9. Nagai H., Hirotsune S., Komatsubara H., et al. Genomic analysis of human hepatocellular carcinomas using restriction landmark genomic scanning. Cancer Detection and Prevention. 17:1993;399-404.
10. Nagai H., Ponglikitmongkol M., Mita E., et al. Alteration of genomic DNA in association with human hepatocellular carcinomas detected by 2-dimensional gel analysis. Cancer Research. 54:1994;1545-1550.
11. Yoshikawa H., De La Monte S., Nagai H., Wands J. R., Matsubara K., Fujiyama A. Chromosomal assignment of human genomic Not I restriction fragments in a two-dimensional electrophoresis profile. Genomics. 31:1996;28-35.
12. Konishi N., Tao M., Nakmura M., Kitahori Y., Hiasa Y., Nagai H. Genomic alterations in human prostate carcinoma cell lines by two-dimensional gel analysis. Cellular and Molecular Biology. 42:1996;1129-1135.
13. Konishi N., Hiasa Y., Nakamura M., Kitahori Y., Matsubara K., Nagai H. Different patterns of DNA alterations detected by restriction landmark genomic scanning in heterogenous prostate carcinomas. American Journal of Pathology. 150:1996;305-314.
14. Hirano Y., Tsutsumi-Ishii Y., Tsuchida N. Roles of p53 mutation in cell line minimum transactivation and transform suppression domain. European Journal of Cancer B Oral Oncology. 31B:1995;129-135.
15. Saeki S., Rikimaru K., Ueda M., et al. The p53 tumor-suppressor gene and ras oncogene mutations in oral squamous cell carcinoma. International Journal of Cancer. 52:1992;867-872.
16. Rikimalu K., Tadokoro K., Yamamoto T., Enomoto S., Tsuchida N. Gene amplification and overexpression of epidermal growth factor receptor in squamous cell carcinoma of head and neck. Head & Neck. 14:1992;8-13.
17. Sakai E., Tsuchida N. Most human squamous cell carcinomas in the oral cavity contain mutated p53 tumor-suppressor genes. Oncogene. 7:1992;927-933.
18. Shi-Yu Z., Andres J. P., Klein-Szanto Edward, R.S., et al. Higher frequency of alterations in the p16/CDKN2 gene in squamous cell carcinoma cell lines than in primary tumors of the head and neck. Cancer Research. 54:1994;5050-5053.
19. Nagai H., Tsumura H., Ponglikitmongkol M., Kim Y.-S., Matsubara K. Genomic aberrations in human hepatoblastomas detected by 2-dimensional gel analysis. Cancer Research. 55:1995;4549-4551.
20. Hirotsune S., Hirose K., Kataoka H., et al. Spot mapping on the standard profile of restriction landmark genomic scanning (RLGS) of sorted chromosome 20 using methylation-insensitive enzyme. Genomics. 24:1994;593-596.
21. Hirsch-Ernst K. I., Poul D., Kahl G. F., Hohne M. W. Expression of c-fos and c-myc protooncogenes in an immortalized hepatocyte line harbouring SV40 T antigen and hGH as transgenes. Transgenic Research. 2:1993;101-108.
22. Muller D., Millon R., Lidereau R., et al. Frequent amplification of 11q13 DNA markers is associated with lymph node involvement in human head and neck squamous cell carcinomas. European Journal of Cancer B Oral Oncology. 30B:1994;113-120.